Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNP105 in Recurrent Aphthous Stomatitis
NCT05772338Unknown
- Sponsor
- EMS
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in recurrent aphthous stomatitis (RAS) comparing BNP105 with Placebo (2 arms). Primary endpoint: Change in pain intensity after the first application. Status: unknown.
02
Drugs
clobetasol
03
Conditions
recurrent aphthous stomatitis (RAS)
Beyond the preview
Go deeper on NCT05772338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05772338.